Risperdal Lawsuit

Men and young boys who experienced breast development after taking a certain antipsychotic drug may be eligible to pursue a Risperdal lawsuit against its manufacturer. By doing so, individuals may receive compensation for the pain and suffering they may have endured as a result of this embarrassing condition, which is also referred to as gynecomastia. This side effect may have resulted in liposuction and mastectomy procedures to remove breast tissue that may have developed out of the drug’s use.

A number of Risperdal gynecomastia lawsuits have also been resolved in settlements from Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals Inc.

The attorneys at Bernstein Liebhard LLP are currently evaluating potential Risperdal lawsuits on behalf of men who developed gynecomastia after taking the medication, and are now offering free case reviews to those eligible to file a lawsuit. Conversely, the Firm is not accepting Risperidone lawsuit claims involving its generic version. If you or someone you love was injured by Risperdal in its brand name form, call our Firm today to learn about your legal rights.

Who Can File a Risperdal Lawsuit?

risperdal lawsuitIndividuals who developed gynecomastia after taking Risperdal may be eligible to pursue a Risperdal lawsuit. Risperdal and its generic version, Risperidone are categorized as atypical antipsychoticsapproved to treat such conditions as schizophrenia and bipolar disorder in adults and adolescents. Children with autism between the ages of 5 and 16 years old are also frequently prescribed this medication, which is sometimes used off-label in the treatment of ADHD. Risperdal was approved by the U.S. Food and Drug Administration (FDA) in 1993. Before losing patent protection, sales of the Johnson & Johnson drug peaked in 2007 at more than $.4.5 billion before falling to $358 million three years later. According to many Risperdal gynecomastia lawsuit claimants, this loss may have led its manufacturer to promote its use for conditions not approved by the FDA.

A study published in a 2006 issue of the Journal of Clinical Psychopharmacology found that Risperdal users may develop high levels of prolactin, a hormone commonly associated with female breast development in young girls and lactation in mothers. Three years later, Journal of Child and Adolescent Psychopharmacology revealed that elevated levels of prolactin may persist up to two years.

Risperdal Gynecomastia Lawsuit Filings Move Forward in Pennsylvania Federal Court

Hundreds of claims against & Johnson, many of which were filed on behalf of Risperdal lawsuit children who allegedly suffered gynecomastia injuries, similarly allege that the company and its Janssen unit failed to adequately warn about side effects in their marketing of the antipsychotic. According to recent court documents, at least 500 claims involving the medication have been centralized in a consolidated litigation established in the Philadelphia Court of Common Pleas in Pennsylvania.

In that the midst of allegations that Johnson & Johnson downplayed gynecomastia side effects in their marketing of Risperdal, a Risperdal lawsuit settlement was reached in November 2013 between the manufacturer and U.S. Department of Justice. Johnson & Johnson agreed to pay $2.2 billion to settle charges over Risperdal after the federal government filed claims that it was improperly marketed for use in children and elderly patients with dementia.

Records indicate that Risperdal lawsuit claims are being filed in the U.S. on a regular basis.

How Do I File a Risperdal Lawsuit?

Call our Firm today to find out about Risperdal lawsuits that allege male gynecomastia and other side effects stemming from the antipsychotic medication. Contact our Firm today at .